LOGIN  |  REGISTER
Astria Therapeutics

Latest Health Technology Stock News

GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women’s Health Imaging

April 18
Last Trade: 85.50 0.53 0.62

Integrated artificial intelligence (AI) and advanced tools improve image quality and exam speed to help providers make accurate diagnoses and tailor precision care for women Latest Voluson Signature ultrasound technology offers an intuitive and ergonomic design allowing clinicians to focus on patient care CHICAGO / Apr 18, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the launch of the Voluson Signature 20 and 18...Read more


Veeva Systems Launches AI Partner Program

April 18
Last Trade: 198.75 -0.79 -0.40

Advanced technology and support to enable the development of GenAI solutions PLEASANTON, Calif., April 18, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the Veeva AI Partner Program to provide partners with the advanced technology and support needed to integrate Generative AI (GenAI) solutions seamlessly with Veeva Vault applications. "Our customers are exploring GenAI solutions across many use cases...Read more


Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment

April 17
Last Trade: 5.75 0.00 0.00

RESEARCH TRIANGLE PARK, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc., the clinical research industry’s leading MetasiteTM, today announced the launch of a stand-alone Patient Recruitment Solution to deliver patients to sites that are eligible, medically reviewed, and fully consented. While traditional central patient recruitment campaigns have proven to be effective in accelerating enrollment, they are fraught with...Read more


CareCloud to Showcase Cutting-Edge Healthcare Technology Solutions at the 2024 Kansas MGMA Conference

April 17
Last Trade: 1.16 0.01 0.87

SOMERSET, N.J., April 17, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, is pleased to announce its participation in the 2024 Kansas MGMA Annual Conference, taking place from April 17-19 at the Wichita Marriott, Kansas. CareCloud will seize this opportunity to showcase its innovative solutions aimed at transforming...Read more


HEALWELL AI Subsidiaries, Khure Health & Pentavere Research Group, to Participate and Present at Upcoming Globally Recognized Medical Conferences

April 17
Last Trade: 1.50 0.00 0.00

Khure Health will be presenting at the National Kidney Foundation Spring Clinical Meetings on May 14-18, 2024 in Long Beach, CA. Pentavere will be presenting at the following medical conferences: Canadian Retina Society Annual Meeting on May 3-5, 2024 in Montreal, QC. American Head & Neck Society Annual Meeting on May 15-16, 2024 in Chicago, IL. American Medical Informatics Association (AMIA) Clinical Informatics Conference on...Read more


Biopharma Leaders Come Together at Veeva Systems Commercial Summit to Advance Customer-Centric Engagement

April 17
Last Trade: 198.75 -0.79 -0.40

Keynote speakers include leaders from Bayer, Genentech, Novo Nordisk, and Takeda sharing strategies for effective commercialization and engagement PLEASANTON, Calif., April 17, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that leaders from Bayer, Genentech, Novo Nordisk, Takeda, and others will be among the keynote speakers at the 2024 Veeva Commercial Summit, May 7-8 in Boston. Commercial and medical affairs...Read more


Veeva Systems Announces Vault CRM Campaign Manager

April 17
Last Trade: 198.75 -0.79 -0.40

Marketing automation with seamless integration to sales drives customer centricity PLEASANTON, Calif., April 17, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Vault CRM Campaign Manager, a new industry-specific marketing application that simplifies and speeds non-personal promotion to healthcare professionals. Vault CRM Campaign Manager lives in the same Vault as Veeva Vault CRM and shares the same customer...Read more


SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)

European-based Unilabs has deployed the SOPHiA DDM™ Platform across its network in Switzerland to support cancer diagnostics and treatment BOSTON and ROLLE, Switzerland, April 17, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Unilabs, one of the largest diagnostic providers in Europe, and the only provider to offer laboratory,...Read more


SHL Telemedicine Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones

April 17
Last Trade: 5.54 0.00 0.00

TEL AVIV, Israel & ZURICH & NEW YORK / Apr 17, 2024 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT; SIX Swiss Exchange: SHLTN) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, announced today its results for the full-year 2023, highlighting fiscally responsible growth across all regions and a strategic focus on expansion and innovation. In 2023, SHL Telemedicine achieved...Read more


Omnicell Announces XT Amplify

April 16
Last Trade: 27.52 0.27 0.99

Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System FORT WORTH, Texas / Apr 16, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced XT Amplify, a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities that...Read more


Definitive Healthcare introduces Carevoyance sales enablement solution for medtech industry

April 16
Last Trade: 6.99 -0.05 -0.71

FRAMINGHAM, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the launch of Carevoyance, an innovative sales enablement solution tailored for medtech organizations. Acquired by Definitive Healthcare in January 2024, Carevoyance tackles frontline sales challenges head-on. It’s a powerful sales acceleration engine that enables medical...Read more


MultiPlan Announces First Quarter 2024 Earnings Conference Call

April 16
Last Trade: 0.75 0.02 2.04

NEW YORK / Apr 16, 2024 / Business Wire / MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will release its first quarter 2024 financial results on Wednesday, May 8, 2024, and hold its conference call that morning at 8:00 am...Read more


Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

April 16
Last Trade: 16.15 -0.06 -0.37

PRINCETON, N.J., April 16, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara Cloud, the unifying platform that integrates its many scientific software solutions. Customers log into Certara Cloud using a single ID to access and manage their licensed software, linking predictive solutions to modeling and analysis of clinical trial results. "This...Read more


OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results

April 16
Last Trade: 9.47 0.12 1.28

Q4 revenue of $28.4 million, increasing 44% year-over-year Q4 gross profit increased 43% year-over-year to $17.8 million with gross margins coming in at 63% for both periods Acquired Healthy Offers, Inc. (dba Medicx Health), a leading healthcare consumer-focused omnichannel marketing and analytics company that significantly expands our footprint with consumers and patients Meaningfully increased our DAAP footprint: 24 DAAP deals in...Read more


Ontrak Announces 2023 Fourth Quarter and Year End Financial Results

April 16
Last Trade: 0.26 -0.01 -5.32

Q4 Revenue of $3.5 million, up 41% year over year; and Full Year Revenue of $12.7 million, down 12% year over year Q4 operating loss of $5.2 million, a 35% improvement year over year; and Full Year operating loss of $21.1 million, a 52% improvement year over year Company expands its services to a larger commercial population as well as eligible self-insured groups with a health plan customer Company completes equity financing...Read more


Mobile-health Network Solutions Makes History as First APAC Telehealth Company Listed on US Stock Exchange

April 15
Last Trade: 23.55 0.00 0.00

SINGAPORE, April 15, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR), a pioneering Asia-Pacific (APAC) telehealth provider, celebrates its successful initial public offering (IPO) on the Nasdaq stock exchange. This achievement marks MNDR as the first pure-play telehealth company from APAC to list on a major US stock exchange. “This IPO is a significant achievement for MNDR and reflects the surging demand for...Read more


LifeWallet Announces Fiscal Year and Fourth Quarter 2023 Financial Results

April 15
Last Trade: 1.02 0.19 22.83

CORAL GABLES, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW) ("LifeWallet," or the "Company"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, announced financial results for the fiscal year and fourth quarter ended December 31, 2023. Highlights The Company announced a comprehensive settlement with 28 affiliated property and casualty...Read more


Mobile-health Network Solutions Announces Closing of Initial Public Offering

April 12
Last Trade: 23.55 0.00 0.00

SINGAPORE, April 12, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (“MNDR” or “the Company”), a leading telehealth solutions provider in Singapore, today announced the closing of its previously announced initial public offering of an aggregate 2,250,000 Class A Ordinary Shares (“the Offering”) at a price of $4.00 per share (“the Offering Price”) to the public, for a total of US$9.0 million of gross proceeds to the Company,...Read more


Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products

April 12
Last Trade: 0.28 -0.02 -7.64

Signifies the first major step towards the application process for the certification of its Mango ED oral dissolvable products by Mexico’s health governing agency, COFEPRIS Dallas, Texas, April 12, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction...Read more


GE HealthCare to feature Mobile Mammography Screening Truck along with Latest AI Platform as part of SBI2024 Breast Cancer Imaging Showcase

April 12
Last Trade: 85.50 0.53 0.62

The latest MyBreastAI Suite* supports clinicians in accelerating breast cancer detection, while the company’s Pristina Bright** solution helps healthcare providers start a new contrast program. MONTREAL / Apr 12, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leader in breast health technology and diagnostics, will feature its latest breast cancer detection technology during the 2024 Society of Breast Imaging Symposium in...Read more


VitalHub Closes $40.25 Million Bought Deal Public Offering with Full Exercise of Over-Allotment Option

April 11
Last Trade: 6.38 -0.02 -0.31

Toronto, Ontario--(Newsfile Corp. - April 11, 2024) - VitalHub Corp. (TSX: VHI) (the "Company" or "VitalHub") is pleased to announce it has closed its previously announced bought deal offering pursuant to a press release dated March 25, 2024. A total of 6,709,000 common shares of VitalHub (the "Common Shares") were sold at a price of $6.00 per Common Share for total gross proceeds of approximately $40.25 million, which included the full...Read more


iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium

April 11
Last Trade: 1.55 -0.04 -2.52

ProFound Cloud, powered by Google Cloud architecture and Google’s Health AI innovations, redefines accessibility to critical insights, empowering radiologists in early breast cancer detection New partnership with Densitas provides end-to-end breast health solution ensuring every aspect of a woman’s breast health journey is addressed Enhanced ProFound Detection Workstation features streamline mammogram interpretation for...Read more


Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care

April 11
Last Trade: 5.54 0.00 0.00

Groundbreaking Study reveals a 76% drop in hospital readmissions and a 41% decrease in Emergency Department visits, underscoring SHL and SmartHeart®’s pivotal role in remote cardiac care TEL AVIV & ZURICH & NEW YORK / Apr 11, 2024 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is excited to announce the...Read more


Netramark's AI-Based Clinical Solution Identifies Novel Lung And Colon Cancer Biomarkers And Patient Subpopulations

April 10
Last Trade: 0.31 0.00 0.00

Insights open the door for potential precision immunotherapy innovation targeting novel pathways and patient enrichment strategies with the potential to improve clinical trial success rates  TORONTO, April 10, 2024 /CNW/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a generative AI software leader in clinical trial analytics, announces the presentation of new data...Read more


Mobile-health Network Solutions Announces Pricing of $9 Million Initial Public Offering

April 9
Last Trade: 23.55 0.00 0.00

Singapore, April 09, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (“MNDR” or the “Company”), a leading telehealth solutions provider in Singapore, today announced the pricing of its firm commitment initial public offering of an aggregate 2,250,000 Class A Ordinary Shares (the “Offering”). The Offering is priced at $4.00 per share (the “Offering Price”). The Company has granted the underwriter a 45-day option to purchase up to...Read more


Cloud DX Signs New Contracts with 2 Ontario Community Paramedic Services

April 9
Last Trade: 0.13 0.00 0.00

These contracts cap a record first quarter at Cloud DX, which has announced 10 new contracts and 14 contract renewals, valued at $4.75M CAD so far in 2024. News in Summary On March 26, 2024, Cloud DX signed new 24-month Master Deployment Agreements with both the Beausoleil First Nation Paramedic Service and another Ontario County Paramedic Service.
 In Ontario, Remote Patient Monitoring (RPM) services are offered in the community...Read more


BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo

April 9
Last Trade: 3.01 -0.01 -0.47

GAITHERSBURG, Md., April 09, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that its Chief Scientific Officer (CSO), Tom Chittenden, will be presenting at the Quantum Computing...Read more


iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation

April 9
Last Trade: 1.55 -0.04 -2.52

Provides a holistic breast health solution, including breast cancer screening focused on quality, safety and efficiency, breast cancer detection, breast density assessment, and risk evaluation Expands access to iCAD’s AI-powered ProFound Breast Health Suite and Densitas’ AI solutions to patients and medical professionals worldwide NASHUA, N.H. and HALIFAX, Nova Scotia, April 09, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a...Read more


Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care

April 9
Last Trade: 2.98 -0.03 -1.00

SAN FRANCISCO and ORLANDO, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- In a significant move to streamline healthcare workflows and allow clinicians to focus on patient care, Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today that it has integrated with Andor Health, an AI-first cloud-based communication and collaboration platform for virtual care. The alliance aims to harness the power...Read more


iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting

April 8
Last Trade: 1.55 -0.04 -2.52

NASHUA, N.H., April 08, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today that new data indicates its AI-powered solution effectively uncovers calcium deposits in the breast vessels, a sign of possible cardiovascular disease in women. iCAD research collaborator Chirag Parghi, M.D., Chief Medical Officer of Solis Mammography, presented the...Read more


SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment

April 8
Last Trade: 5.54 0.00 0.00

SHL’s SmartHeart portable 12-lead ECG technology successfully participated in the U.S. Army’s Project Convergence – Capstone 4 experiment (PC-C4), demonstrating exceptional reliability, user-friendliness, and effectiveness, even in extreme scenarios. TEL AVIV, Israel & ZURICH & NEW YORK / Apr 08, 2024 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer...Read more


Renalytix Announces Financing with Expected Size of up to $4 Million

April 8
Last Trade: 0.78 -0.01 -1.27

LONDON and SALT LAKE CITY, April 08, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces a registered direct offering of ordinary shares at a purchase price equivalent to $0.75 per NASDAQ ADS ($0.375 per common stock share) (£0.0025 each) (the “Ordinary Shares”) (the “Fundraise”) to DB Capital Partners Healthcare, L.P. (the “Purchaser”), a specialty healthcare institutional investor focused on innovative medical...Read more


Cloud DX Announces Proposed $2.8 Million Private Placement

April 8
Last Trade: 0.13 0.00 0.00

KITCHENER, ON / ACCESSWIRE / April 8, 2024 / Cloud DX Inc. ("Cloud DX" or the "Company") (TSXV:CDX) (OTC:CDXFF) is pleased to announce a non-brokered private placement (the "Private Placement") for gross proceeds of up to $2,800,000 through the issuance of up to 23,333,334 units (each, a "Unit") of the Company at a price of $0.12 per Unit. The Company reserves the right to oversubscribe the Private Placement by up to $500,000, pursuant to...Read more


Teladoc Health Board of Directors Announces Leadership Transition

April 5
Last Trade: 13.07 -0.12 -0.91

Jason Gorevic to depart the company, effective immediately CFO Mala Murthy appointed acting chief executive Teladoc Health reaffirms guidance PURCHASE, NY, April 05, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today announced that Jason Gorevic is departing the company, effective immediately. The Board of Directors has appointed Mala Murthy acting Chief Executive...Read more


Simulations Plus: U.S. FDA Renews DILIsym® Software Licenses for 7th Year

April 4
Last Trade: 44.62 0.21 0.47

Predicting DILI risk supports informed decision-making regarding drug evaluations and approvals LANCASTER, Calif. / Apr 04, 2024 / Business Wire / Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that the U.S. FDA has renewed its licenses to the DILIsym® software platform. DILIsym is the industry...Read more


Healthcare Triangle Announces Strategic Partnership with Cynomi to Enhance Cybersecurity in Healthcare

April 4
Last Trade: 1.38 -0.01 -0.98

PLEASANTON, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), a leading provider of healthcare IT solutions, is thrilled to announce its partnership with Cynomi, a pioneer vCISO platform vendor. This collaboration introduces an innovative Virtual Chief Information Security Officer (vCISO) service tailored specifically for the healthcare provider market,...Read more


Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide

April 4
Last Trade: 2.98 -0.03 -1.00

SAN FRANCISCO, April 04, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced its go-to-market partnership with SADA, an Insight company, a leading cloud business and technology consultancy. The collaboration is focused on leveraging the companies’ combined technology expertise and expanding their reach to provide greater product and service value to health...Read more


HEALWELL AI’s Pentavere Achieves Validation of Generative AI for Preventative Care Through Landmark Publication

April 4
Last Trade: 1.50 0.00 0.00

Pentavere has published industry’s first peer-reviewed paper utilizing AI and large language models (or LLMs) to identify rare lung cancer patients. Industry applications may include Real World Evidence generation, identification of areas of unmet clinical need and optimization of cancer therapy and care pathways. Pentavere is an AI-powered patient identification company and this validated instance of identifying cancer patients using...Read more


SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership

April 4
Last Trade: 4.81 0.01 0.21

The companies will join forces to advance the use of precision medicine on a global scale BOSTON and ROLLE, Switzerland, April 4, 2024 /CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced a strategic partnership with Strand Life Sciences, a pioneer in bioinformatics and diagnostics, to deliver innovative solutions that will fuel...Read more


Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results

April 3
Last Trade: 44.62 0.21 0.47

Total revenue of $18.3 million and diluted earnings per share (EPS) of $0.20 Maintains full-year revenue guidance of $66 to $69 million (+10-15%) and EPS guidance of $0.66 to $0.68 LANCASTER, Calif. / Apr 03, 2024 / Business Wire / Simulations Plus, Inc. (NASDAQ: SLP) (“Simulations Plus”), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for...Read more


GE HealthCare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images

Caption AI on Vscan Air SL expands access to cardiac care by enabling more medical professionals to feel confident acquiring images for rapid assessments AutoEF feature automatically calculates ejection fraction, saving time for clinicians while delivering key information for making their diagnoses GE HealthCare to debut new technology at 2024 American College of Cardiology Annual Scientific Session & Expo, April 6 – 8, 2024 in...Read more


Healthcare Triangle Breaks New Ground in AI-Powered Patient Data Management with readabl.ai

April 3
Last Trade: 1.38 -0.01 -0.98

PLEASANTON, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), In a pioneering move, a leading health system has partnered with Healthcare Triangle to utilize a groundbreaking cloud-based AI and machine learning solution. This collaboration establishes a revolutionary benchmark in the management and utilization of patient data, ultimately elevating the...Read more


iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)

April 3
Last Trade: 1.55 -0.04 -2.52

NASHUA, N.H., April 03, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, is proud to announce a philanthropic global health collaboration with RAD-AID International. RAD-AID, a non-profit charitable organization dedicated to improving radiology healthcare in medically underserved regions, is collaborating with iCAD to introduce mammography AI-based decision...Read more


iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale

April 2
Last Trade: 1.55 -0.04 -2.52

NASHUA, N.H., April 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, today announced commercial availability of ProFound Cloud. The innovative Software-as-a-Service (SaaS) platform provides medical providers with a cost-effective, secure, and scalable means to access and deploy the latest ProFound Breast Health Suite of AI solutions. “With the commercial...Read more


OneMedNet Announces CEO Succession Plan

April 2
Last Trade: 0.65 -0.0003 -0.05

President, Aaron Green, Assumes Role of Chief Executive Officer  CEO, Paul Casey, Announces Retirement and Shift to Active Advisory Role to Guide Transition Successfully  Casey to Remain on Board Post-Transition  MINNEAPOLIS, April 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), the leading curator of regulatory-grade imaging Real World Data (“iRWD™”), today announced that its President, Aaron...Read more


GE HealthCare closes MIM Software acquisition, bolstering its portfolio and advancing its precision care strategy

April 1
Last Trade: 85.50 0.53 0.62

With the addition of MIM Software, GE HealthCare aims to provide clinicians and healthcare systems with increasingly integrated and automated solutions, meeting the evolving needs of providers, and reinforcing a shared legacy of advanced patient care solutions Portfolio additions include AI-enabled image analysis and workflow tools spanning multiple care areas, including oncology, urology, neurology, and cardiology CHICAGO / Apr 01,...Read more


Sharecare announces fourth quarter and full year 2023 financial results and operational highlights

March 28
Last Trade: 0.63 -0.0051 -0.80

ATLANTA, March 28, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced financial results for the quarter and year ended December 31, 2023. "In my first three months as CEO, I have been increasingly impressed by Sharecare's ability to innovate, and I believe that the breadth and depth of assets that the company has assembled over the...Read more


HEALWELL AI Reports Q4 and Full Year 2023 Financial Results

March 28
Last Trade: 1.50 0.00 0.00

HEALWELL AI achieved annual revenue from continuing operations of $7.32 million in fiscal 2023. HEALWELL ended 2023 with a strong balance sheet, having secured approximately $29.5 million from convertible debt and equity financings. Since its relaunch in Q4 2023, the Company’s annual revenue run rate has more than doubled to over $20M with the largest component of revenues now coming from SaaS and services. Management provides a...Read more


Forian Announces Fourth Quarter and Full Year 2023 Financial Results

March 28
Last Trade: 2.54 0.02 0.79

Full Year 2023 Revenue Grew 25% Full Year 2023 Adjusted EBITDA of $2.3MM NEWTOWN, PA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter and year ended December 31, 2023. “Forian finished the year by executing against our quarterly plan and...Read more


GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist

March 27
Last Trade: 85.50 0.53 0.62

Prostate Volume Assist (PVA) is the company’s proprietary urology-based artificial intelligence (AI) software feature designed to automate the manual process for generating prostate volume measurements New AI software feature will be available for use on the bkActiv, bk3000/5000 and bkSpecto active imaging systems Addition of AI solution advances leadership in urological active imaging CHICAGO / Mar 27, 2024 / Business Wire / GE...Read more


10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay

March 26
Last Trade: 28.70 -0.25 -0.86

Began global shipments for Visium HD, a new product that enables whole transcriptome spatial discovery at single cell–scale resolution  PLEASANTON, Calif., March 26, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Visium HD Spatial Gene Expression product. This assay enables researchers to measure the whole transcriptome from...Read more


Jersey Hydreight Selects CareCloud’s talkUltimate to Elevate Patient Experiences and Streamline Administrative Processes

March 26
Last Trade: 1.16 0.01 0.87

SOMERSET, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leading provider of healthcare technology solutions for medical practices and health systems nationwide, today announced that Jersey Hydreight (Hydreight) has selected CareCloud’s talkUltimate to improve the patient experience and streamline administrative processes. Hydreight, a prominent provider of intravenous and nonsurgical aesthetic...Read more


HEALWELL AI’s Intrahealth Provides Update on New Customer Implementation with Toronto Public Health

March 26
Last Trade: 1.50 0.00 0.00

Intrahealth is pleased to report on a recent customer implementation with Toronto Public Health, a health unit responsible for delivering public health programs and services, enforcing public health regulations, and reporting to the Toronto Board of Health on public health issues. Intrahealth now serves more public health units across Ontario than any other provider of Electronic Health Records (EHR) software.   Intrahealth...Read more


GE HealthCare Announces the FDA Clearance of nCommand Lite by IONIC Health

March 25
Last Trade: 85.50 0.53 0.62

GE HealthCare to exclusively distribute nCommand Lite by IONIC Health for multi-vendor, multi-modality remote operations capabilities CHICAGO / Mar 25, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) announces the U.S. FDA 510(k) Clearance of IONIC Health’s nCommand Lite technology. The vendor-agnostic, multi-modality nCommand Lite system will be distributed exclusively by GE HealthCare and will provide remote patient scanning...Read more


VitalHub Announces $35.0 Million Bought Deal Public Offering

March 25
Last Trade: 6.38 -0.02 -0.31

TORONTO, March 25, 2024 /CNW/ - VitalHub Corp. (the "Company" or "VitalHub") (TSX: VHI) is pleased to announce that it has entered into an agreement with Cormark Securities Inc. acting as lead underwriter, on behalf of a syndicate of underwriters (collectively, the "Underwriters") pursuant to which the Underwriters have agreed to purchase 5,834,000 Common Shares (the "Common Shares") from the treasury of the Company, at a price of...Read more


GE HealthCare to Feature Latest Technologies in Interventional Radiology Focused on Precision Care at SIR 2024

March 22
Last Trade: 85.50 0.53 0.62

Multi-modality showcase brings hands-on experience to care delivery for a wide range of vascular diseases and health conditions Scientific studies provide evidence that Embo ASSIST solution can help clinicians reduce patient dose, fluoroscopy time and overall procedure time while performing prostate artery embolization (PAE) CHICAGO / Mar 22, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) will showcase its latest technologies in...Read more


VML and Definitive Healthcare announce partnership to transform key opinion leader management

March 22
Last Trade: 6.99 -0.05 -0.71

FRAMINGHAM, Mass. and LONDON, March 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH) and VML Health announced a first-of-its-kind partnership that gives clients the ability to manage their entire key opinion leader (KOL) identification and engagement operation from an integrated solution. This partnership provides an answer to the increasingly complex challenges that the health industry faces when identifying and...Read more


VitalHub Reports Fourth Quarter and Year-End 2023 Results

March 21
Last Trade: 6.38 -0.02 -0.31

TORONTO, March 21, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX:VHI) (OTCQX:VHIBF) announced today it has filed its Consolidated Financial Statements and Management's Discussion and Analysis report for the year ended December 31, 2023, with the Canadian securities authorities. These documents may be viewed under the Company’s profile at www.sedar.com. "As VitalHub closes another quarter, it's with a great...Read more


10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel

March 21
Last Trade: 28.70 -0.25 -0.86

Begins commercial shipments of Xenium Cell Segmentation Kit to improve determination of cell boundaries Launches first Xenium application-focused panel optimized for immuno-oncology across all tissue types PLEASANTON, Calif., March 21, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Xenium multi-modal cell segmentation kit...Read more


Ontrak Health Announces Launch of Ontrak Advanced Engagement System, Ushering in the Next Era of AI-enabled Behavioral Healthcare

March 21
Last Trade: 0.26 -0.01 -5.32

MIAMI / Mar 21, 2024 / Business Wire / Ontrak Health (NASDAQ: OTRK), a leading AI-powered and tech-enabled behavioral healthcare company, today announced the launch of its Ontrak Advanced Engagement System. This system integrates Augmented Intelligence (AI) with an evidence-based clinical framework to deliver human-centered, personalized member engagement. Built on a foundation of real-world AI application, the Ontrak Advanced Engagement...Read more


HEALWELL AI Provides Corporate Update and Preliminary Financial Results for the Year Ended December 31, 2023

March 21
Last Trade: 1.50 0.00 0.00

HEALWELL debuted in the fourth quarter of 2023 and since then has achieved significant milestones including raising approximately $29.5 million, completing the acquisition of a majority interest in AI healthcare company Pentavere, announcing that it is powering WELL AI Decision Support, the first AI-powered physician co-pilot product adopted by WELL Health Technologies (TSX: WELL), and announcing the acquisition of Intrahealth, an...Read more


LifeSpeak Announces Fourth Quarter and Fiscal 2023 Results

March 21
Last Trade: 0.63 0.00 0.00

Fiscal 2023 revenue of $52.4 million, an increase of 11% over Fiscal 2022 Adjusted EBITDA1 for Fiscal 2023 of $13.0 million, representing an Adjusted EBITDA Margin1 of 25% Total Number of Clients2 of 956 as at December 31, 2023 TORONTO, March 21, 2024 /CNW/ - LifeSpeak Inc. ("LifeSpeak" or the "Company") (TSX: LSPK), the leading whole-person wellbeing solution for employers, health plans and other organizations,...Read more


CareCloud Reports Full Year 2023 Results

March 21
Last Trade: 1.16 0.01 0.87

SOMERSET, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company” or “CareCloud”) (Nasdaq: CCLD, CCLDP and CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced financial and operational results for the year ended December 31, 2023. The Company’s management will conduct a conference call with related slides today at 8:30 a.m. Eastern Time to discuss these results...Read more


Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting

March 20
Last Trade: 24.50 0.16 0.66

NEW ORLEANS / Mar 20, 2024 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today presented the discovery of SGR-1505, its MALT1 inhibitor, during the First Time Disclosure Session at the American Chemical Society (ACS) Spring 2024 Meeting. SGR-1505 is being evaluated in a Phase 1 dose-escalation study in patients with...Read more


SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada

March 20
Last Trade: 4.81 0.01 0.21

University of Saskatchewan's (USask) Advanced Diagnostics Research Laboratory will use SOPHiA DDM™ Platform to advance research on ovarian cancer care BOSTON and ROLLE, Switzerland, March 20, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced the University of Saskatchewan (USask) as its first HRD customer in Canada. USask will implement...Read more


Sign Up To Get Daily Life Science Stock News

Please review our Disclaimer and Privacy Policy before subscribing.

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

COPYRIGHT ©2023 HEALTH STOCKS HUB